Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Jun 8;290(6483):1683–1686. doi: 10.1136/bmj.290.6483.1683

Therapeutic ranges in anticoagulant administration.

L Poller
PMCID: PMC1416105  PMID: 3924215

Full text

PDF
1683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARRITT D. W., JORDAN S. C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960 Jun 18;1(7138):1309–1312. doi: 10.1016/s0140-6736(60)92299-6. [DOI] [PubMed] [Google Scholar]
  2. Chalmers T. C., Matta R. J., Smith H., Jr, Kunzler A. M. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med. 1977 Nov 17;297(20):1091–1096. doi: 10.1056/NEJM197711172972004. [DOI] [PubMed] [Google Scholar]
  3. DUNN H. P. Postcoital examination of semen. Lancet. 1959 Nov 28;2(7109):974–974. doi: 10.1016/s0140-6736(59)91625-3. [DOI] [PubMed] [Google Scholar]
  4. Forfar J. C. A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment. Br Heart J. 1979 Aug;42(2):128–132. doi: 10.1136/hrt.42.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hull R., Delmore T., Carter C., Hirsh J., Genton E., Gent M., Turpie G., McLaughlin D. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med. 1982 Jan 28;306(4):189–194. doi: 10.1056/NEJM198201283060401. [DOI] [PubMed] [Google Scholar]
  6. Hull R., Delmore T., Genton E., Hirsh J., Gent M., Sackett D., McLoughlin D., Armstrong P. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med. 1979 Oct 18;301(16):855–858. doi: 10.1056/NEJM197910183011602. [DOI] [PubMed] [Google Scholar]
  7. Hull R., Hirsh J., Jay R., Carter C., England C., Gent M., Turpie A. G., McLoughlin D., Dodd P., Thomas M. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med. 1982 Dec 30;307(27):1676–1681. doi: 10.1056/NEJM198212303072704. [DOI] [PubMed] [Google Scholar]
  8. Kennedy J. W., Ritchie J. L., Davis K. B., Fritz J. K. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983 Dec 15;309(24):1477–1482. doi: 10.1056/NEJM198312153092402. [DOI] [PubMed] [Google Scholar]
  9. Loeliger E. A., Lewis S. M. Progress in laboratory control of oral anticoagulants. Lancet. 1982 Aug 7;2(8293):318–320. doi: 10.1016/s0140-6736(82)90283-5. [DOI] [PubMed] [Google Scholar]
  10. Mitchell J. R. Anticoagulants in coronary heart disease--retrospect and prospect. Lancet. 1981 Jan 31;1(8214):257–262. doi: 10.1016/s0140-6736(81)92095-x. [DOI] [PubMed] [Google Scholar]
  11. Modan B., Shani M., Schor S., Modan M. Reduction of hospital mortality from acute myocardial infarction by anticoagulant therapy. N Engl J Med. 1975 Jun 26;292(26):1359–1362. doi: 10.1056/NEJM197506262922601. [DOI] [PubMed] [Google Scholar]
  12. Morris G. K., Mitchell J. R. Clinical management of venous thrombo-embolism. Br Med Bull. 1978 May;34(2):169–175. doi: 10.1093/oxfordjournals.bmb.a071488. [DOI] [PubMed] [Google Scholar]
  13. Poller L., Taberner D. A. Dosage and control of oral anticoagulants: an international collaborative survey. Br J Haematol. 1982 Jul;51(3):479–485. doi: 10.1111/j.1365-2141.1982.tb02805.x. [DOI] [PubMed] [Google Scholar]
  14. SEVITT S., INNES D. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY. Lancet. 1964 Jan 18;1(7325):124–129. doi: 10.1016/s0140-6736(64)92218-4. [DOI] [PubMed] [Google Scholar]
  15. Taberner D. A., Poller L., Burslem R. W., Jones J. B. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J. 1978 Feb 4;1(6108):272–274. doi: 10.1136/bmj.1.6108.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Van de Werf F., Ludbrook P. A., Bergmann S. R., Tiefenbrunn A. J., Fox K. A., de Geest H., Verstraete M., Collen D., Sobel B. E. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med. 1984 Mar 8;310(10):609–613. doi: 10.1056/NEJM198403083101001. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES